These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 20581790

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B.
    Neuropsychobiology; 2003 Sep; 48(4):194-208. PubMed ID: 14673218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo.
    Kornstein SG, Fava M, Jiang Q, Tourian KA.
    Psychopharmacol Bull; 2009 Sep; 42(3):21-35. PubMed ID: 19752839
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L, Xie WW, Li LH, Zhang HG, Wang G, Chen DC, Cao Y, Cui LJ, Zhang KR, Shi JG, Tan QR, Zheng HB, Xu XF, Cheng ZH, Zhao JP.
    Pharmacology; 2014 Sep; 94(5-6):199-206. PubMed ID: 25376160
    [Abstract] [Full Text] [Related]

  • 9. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A, Amodeo G, Goracci A, Blardi P.
    Riv Psichiatr; 2016 Sep; 51(4):123-128. PubMed ID: 27727261
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
    Trivedi MH, Bandelow B, Demyttenaere K, Papakostas GI, Szamosi J, Earley W, Eriksson H.
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Sep; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 18. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O, Murphy JR, Staner L, Hoffmann G, Kormoss N, Kentos M, Dupont P, Lion K, Pelc I, Verbanck P.
    J Clin Psychopharmacol; 2003 Aug 01; 23(4):377-83. PubMed ID: 12920414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.